Publications

miR-19, miR-345, miR-519c-5p serum levels predict adverse pathology in prostate cancer patients eligible for active surveillance

Wang SY, Shiboski S, Belair CD, Cooperberg MR, Simko JP, Stoppler H, Cowan J, Carroll PR, Blelloch R.
PLoS One. 2014 Jun 3;9(6):e98597. doi: 10.1371/journal.pone.0098597. eCollection 2014.

Two miRNA clusters reveal alternative paths in late-stage reprogramming

Parchem RJ, Ye J, Judson RL, LaRussa MF, Krishnakumar R, Blelloch A, Oldham MC, Blelloch R.
Cell Stem Cell. 2014 May 1;14(5):617-31. doi: 10.1016/j.stem.2014.01.021. Epub 2014 Mar 13.

MicroRNA-based discovery of barriers to dedifferentiation of fibroblasts to pluripotent stem cells

Judson RL, Greve TS, Parchem RJ, Blelloch R.
Nat Struct Mol Biol. 2013 Oct;20(10):1227-35. doi: 10.1038/nsmb.2665. Epub 2013 Sep 15.

Epigenetics of cellular reprogramming

Krishnakumar R, Blelloch RH.
Curr Opin Genet Dev. 2013 Oct;23(5):548-55. doi: 10.1016/j.gde.2013.06.005. Epub 2013 Aug 12. Review.

Pages